Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients

  1. Ocio, E.M.
  2. Bringhen, S.
  3. Martinez-Lopez, J.
  4. San-Miguel, J.
  5. Oliva, S.
  6. Rodriguez-Otero, P.
  7. Le Roux, N.
  8. Dong, Y.
  9. Doroumian, S.
  10. Macé, S.
  11. Mateos, M.-V.
Journal:
HemaSphere

ISSN: 2572-9241

Year of publication: 2023

Volume: 7

Issue: 2

Pages: E829

Type: Letter

DOI: 10.1097/HS9.0000000000000829 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals